RMTG — Regenerative Medical Technology Group Inc.
—
OTC ·
Consumer Discretionary ·
Specialty Retail ·
CIK 1760026 ·
Last close
$0.04
Market Cap
$478.8K
52W High
$0.04
52W Low
$0.02
ADV30
9,294
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,571,922 | 779,495 | -306,274 | -1,392,843 | 4,488,694 | 956,718 | 39,233,729 |
| Sep 2025 | 1,180,534 | 501,557 | -445,761 | -4,353,741 | 4,519,827 | 1,185,695 | 34,574,268 |
| Jun 2025 | 983,518 | 585,832 | -250,086 | -1,305,785 | 4,486,828 | 1,614,254 | 33,508,078 |
| Mar 2025 | 1,364,341 | 943,894 | 134,960 | -760,040 | 3,980,768 | 1,222,929 | 32,097,480 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-365,322
Investing CF
$-385,411
Financing CF
$0
CapEx
$-328,437
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.58
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-73,972,668
Inventory
$155,886
Receivables
$114,006
ST Investments
—
EBIT TTM
$-597,881
Pretax Income TTM
$-7,057,753
Interest Exp TTM
$6,459,872
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 5,100,315 | -867,162 | -7,812,409 | 4,488,694 | 39,233,729 | — | -706,519 |
| Dec 2024 | 4,107,494 | 81,181 | -5,562,971 | 3,821,429 | 31,178,102 | — | 850,699 |
| Dec 2023 | 2,409,953 | -715,227 | -9,813,666 | 2,879,103 | 24,674,606 | — | -419,199 |
| Dec 2022 | 1,530,223 | -1,184,859 | -5,506,822 | 8,080,273 | 20,062,565 | — | -1,114,136 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NSTM | NovelStem International Corp. | $493.3K | $0.01 | — |
| SNBH | SENTIENT BRANDS HOLDINGS INC. | $181.9K | $0.04 | — |
| JZXN | Jiuzi Holdings, Inc. | $1.48M | $1.11 | — |
| FBCD | FBC Holding, Inc. | $2.03M | $0.00 | — |
| JEM | 707 Cayman Holdings Ltd. | $2.13M | $1.51 | — |
News headlines (Yahoo Finance, 1h cache)
RMTG Subsidiary Cellgenic Commences Full-Scale Manufacturing at First-of-Its-Kind
2026-03-26 11:55 · Yahoo
RMTG Subsidiary CELLGENIC Introduces Peptide Pen Product Line at Cancún Global Summit
2025-11-18 12:59 · Yahoo
RMTG Subsidiary CELLGENIC Expands into Dominican Republic with New Distribution Partnership
2025-10-21 11:59 · Yahoo
RMTG Expands into Brazil with Strategic Representation Agreement
2025-10-14 11:59 · Yahoo
RMTG's ISSCA Regenerative Medicine Global Summit 2025 Concludes in Cancún with Full Attendance from 30+ Countries
2025-10-08 11:59 · Yahoo
RMTG Partners with BKFC as Official Regenerative Medicine Provider
2025-09-29 12:00 · Yahoo
RMTG Subsidiary Cellgenic to Host Soft Opening of Advanced Cell Therapy Manufacturing Lab in Cancun During September ISSCA Global Summit
2025-08-25 12:00 · Yahoo
RMTG Expands to Northern Argentina and Paraguay with New Affiliate Partnership
2025-07-29 12:00 · Yahoo
RMTG's Successful ISSCA Buenos Aires Argentina Event Draws Hundreds of Physicians, Announces Seven Additional Training Events in 2025
2025-07-24 12:00 · Yahoo
RMTG Expands to Puerto Rico with New Affiliate Partnership
2025-07-21 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.